Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Peregrine Pharmaceuticals Inc (PPHM)

2014-12-15@13:42:21 ET
Peregrine Pharmaceuticals Down 6.1%, Shares Slide into the Red (PPHM) (PSM)

2014-12-12@21:05:09 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-12-12@08:00:54 ET
Data to Be Presented at 2014 San Antonio Breast Cancer Symposium Demonstrate Immune-Stimulatory Properties of Peregrine Pharmaceuticals' Bavituximab in Models of Breast Cancer (INW)

2014-12-11@21:11:14 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-12-10@21:12:58 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-12-10@16:22:49 ET
10-Q: PEREGRINE PHARMACEUTICALS INC (EDG)

2014-12-10@16:02:43 ET
Peregrine Pharmaceuticals Reports Second Quarter Fiscal Year 2015 Financial Results and Recent Developments (INW)

2014-12-09@16:00:13 ET
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock (INW)

2014-12-03@21:02:43 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-12-03@16:00:30 ET
Peregrine Pharmaceuticals to Report Second Quarter Fiscal 2015 Financial Results After Market on December 10, 2014 (INW)

2014-11-27@20:51:42 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-11-26@21:04:51 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-11-12@21:36:45 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-11-11@21:36:04 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-11-10@07:31:33 ET
Phase II Clinical Data Presented at SITC Annual Meeting Support Immunotherapeutic Mechanism of Action of Peregrine Pharmaceuticals' Bavituximab in Liver Cancer (INW)

2014-11-07@07:45:20 ET
Data to Be Presented at the SITC Annual Meeting Support Synergy of PS-Targeting and Anti-CTLA-4 Immunotherapies to Enhance Anti-Tumor Treatments in Melanoma (INW)

2014-11-05@08:46:17 ET
Form 4: Update Filing for Peregrine Pharmaceuticals Inc (PPHM) (VKR)

2014-11-05@08:46:05 ET
Form 4: Update Filing for Peregrine Pharmaceuticals Inc (PPHM) (VKR)

2014-10-30@09:42:58 ET
Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer (INW)

2014-10-24@09:00:00 ET
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells (PRN)